Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
63 participants
OBSERVATIONAL
2024-10-15
2026-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validity and Reliability of the Turkish Version of the 4-Item Short Form of the Pain Anxiety Symptom Scale
NCT06758973
Prevalence of Urinary Incontinence and Identification of Risk Factors Among Female Medical Students
NCT07116603
Physiotherapy and Rehabilitation Students' Incontinence Knowledge Level
NCT05702164
Urinary Incontinence and Transtheoretical Model
NCT04688047
The Effect of Program on Women's Urinary Incontinence Awareness and Health Beliefs
NCT04689113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this context, the study consists of two phases. In the first phase, the PRAFAB questionnaire was translated into Turkish and culturally adapted; in the second phase, the validity and reliability analyses of the Turkish version of the PRAFAB questionnaire (PRAFAB-Turkish) were conducted.
The study will be conducted by Afyonkarahisar University of Health Sciences. Participants consisted of women who presented as outpatients at the AFSU Health Application and Research Center Urology Clinic and were diagnosed with urinary incontinence by a urologist.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Urinary Incontinence
All subtypes of urinary incontinence (stress urinary incontinence, urge incontinence, etc.) were included in our study.
Construct validity
This is not an intervention. This is an analysis conducted to examine the factor structure of this questionnaire. The analysis will be performed using the SPSS 26.0 software package program.
Test-retest reliability
This is not an intervention. This is an analysis conducted to examine the repeatability of this questionnaire. The analysis will be performed using the SPSS 26.0 software package program.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Construct validity
This is not an intervention. This is an analysis conducted to examine the factor structure of this questionnaire. The analysis will be performed using the SPSS 26.0 software package program.
Test-retest reliability
This is not an intervention. This is an analysis conducted to examine the repeatability of this questionnaire. The analysis will be performed using the SPSS 26.0 software package program.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have been diagnosed with urinary incontinence by a urologist
* Be female
Exclusion Criteria
* Being in the early postpartum period,
* Have been diagnosed with bladder cancer, diabetic nephropathy, a history of central nervous system damage, congenital urological disorders, urinary tract infection, neurogenic bladder, severe cognitive impairment, and severe psychiatric illness.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Afyonkarahisar Health Sciences University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emel Taşvuran Horata
PhD; Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
EMEL TAŞVURAN HORATA
Role: PRINCIPAL_INVESTIGATOR
Afyonkarahisar Sağlık Bİlimleri Üniversitesi
Şeyma Betül İNCE
Role: STUDY_CHAIR
No Affiliation
Harun TAŞKIN, PhD
Role: STUDY_CHAIR
Afyonkarahisar Health Sciences University
Osman GERÇEK, MD
Role: STUDY_CHAIR
Afyonkarahisar Health Sciences University
Mustafa Esat İNCE, MD
Role: STUDY_CHAIR
Afyonkarahisar Health Sciences University
Bary Berghmans, Assoc. Prof.
Role: STUDY_CHAIR
Maastricht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emel Taşvuran Horata
Afyonkarahisar, Merkez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
291
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.